146 related articles for article (PubMed ID: 16831592)
21. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
Ikeda M; Abe K; Yamada M; Dansako H; Naka K; Kato N
Hepatology; 2006 Jul; 44(1):117-25. PubMed ID: 16799963
[TBL] [Abstract][Full Text] [Related]
22. [Association of chronic hepatitis C and lichen planus--in two patients].
Podányi B; Lengyel G; Kiss A; Szakonyi J; Schaff Z; Fehér J
Orv Hetil; 2006 Mar; 147(12):547-50. PubMed ID: 16696378
[TBL] [Abstract][Full Text] [Related]
23. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection.
Navas MC; Fuchs A; Schvoerer E; Bohbot A; Aubertin AM; Stoll-Keller F
J Med Virol; 2002 Jun; 67(2):152-61. PubMed ID: 11992576
[TBL] [Abstract][Full Text] [Related]
24. Quasispecies nature of hepatitis C virus (HCV) in patients with chronic hepatitis C with mixed HCV subtypes.
Toyoda H; Fukuda Y; Nakano I; Katano Y; Takayama T; Kumada T; Nakano S; Takamatsu J; Saito H; Hayakawa T
J Med Virol; 1998 Feb; 54(2):80-5. PubMed ID: 9496363
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus 5' untranslated region variability correlates with treatment outcome.
Bukowska-Ośko I; Radkowski M; Pawełczyk A; Rosinska M; Caraballo Cortés K; Płoski R; Berak H; Horban A; Stanczak J; Fic M; Laskus T
J Viral Hepat; 2014 Aug; 21(8):551-9. PubMed ID: 24118647
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.
Castillo I; Rodríguez-Iñigo E; Bartolomé J; de Lucas S; Ortíz-Movilla N; López-Alcorocho JM; Pardo M; Carreño V
Gut; 2005 May; 54(5):682-5. PubMed ID: 15831916
[TBL] [Abstract][Full Text] [Related]
27. [Clinical implications of HCV quasispecies heterogeneity in patients with hepatitis C].
Tang X; Qian K; Lau JY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):173-5. PubMed ID: 11436653
[TBL] [Abstract][Full Text] [Related]
28. Detection of HCV and GBV-CHGV RNA in peripheral blood mononuclear cells of patients with chronic type C hepatitis.
García F; García F; Roldán C; López I; Martínez NM; Alvarez M; Bernal MC; Hernández J; Maroto MC
Microbios; 2000; 103(404):7-15. PubMed ID: 11034441
[TBL] [Abstract][Full Text] [Related]
29. Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes.
Durand T; Di Liberto G; Colman H; Cammas A; Boni S; Marcellin P; Cahour A; Vagner S; Féray C
Gut; 2010 Jul; 59(7):934-42. PubMed ID: 20442199
[TBL] [Abstract][Full Text] [Related]
30. [Hepatitis C virus variability and interferon-mediated pathway inhibition].
Fernández B; Basaras M; Blanco S; Sánchez S; Arrese E; de las Heras B; Cisterna R
Rev Esp Quimioter; 2003 Sep; 16(3):325-9. PubMed ID: 14702125
[TBL] [Abstract][Full Text] [Related]
31. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients.
Maggi F; Fornai C; Morrica A; Vatteroni ML; Giorgi M; Marchi S; Ciccorossi P; Bendinelli M; Pistello M
J Med Virol; 1999 Jan; 57(1):57-63. PubMed ID: 9890422
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.
Grahovac B; Bingulac-Popovic J; Vucelic B; Hrstic I; Ostojic R; Drazic V; Balija M; Grgicevic D
J Clin Virol; 2001 Jan; 20(1-2):85-9. PubMed ID: 11163588
[TBL] [Abstract][Full Text] [Related]
33. [Epidemiological and clinical characteristics of genotype 4 HCV infection in the north-east Poland].
Łapiński TW; Pawluczuk P; Flisiak R
Przegl Epidemiol; 2009; 63(4):501-4. PubMed ID: 20120947
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
Arenas JI; Gallegos-Orozco JF; Laskus T; Wilkinson J; Khatib A; Fasola C; Adair D; Radkowski M; Kibler KV; Nowicki M; Douglas D; Williams J; Netto G; Mulligan D; Klintmalm G; Rakela J; Vargas HE
J Infect Dis; 2004 Jun; 189(11):2037-46. PubMed ID: 15143471
[TBL] [Abstract][Full Text] [Related]
35. IRES complexity before IFN-alpha treatment and evolution of the viral load at the early stage of treatment in peripheral blood mononuclear cells from chronic hepatitis C patients.
Thélu MA; Leroy V; Ramzan M; Dufeu-Duchesne T; Marche P; Zarski JP
J Med Virol; 2007 Mar; 79(3):242-53. PubMed ID: 17245718
[TBL] [Abstract][Full Text] [Related]
36. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.
Vargas HE; Laskus T; Radkowski M; Wilkinson J; Balan V; Douglas DD; Harrison ME; Mulligan DC; Olden K; Adair D; Rakela J
Liver Transpl; 2002 Nov; 8(11):1014-9. PubMed ID: 12424714
[TBL] [Abstract][Full Text] [Related]
37. [Genetic variation characteristics of the envelope region of hepatitis C virus in the patients with chronic hepatitis].
Chen S; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):219-22. PubMed ID: 12665923
[TBL] [Abstract][Full Text] [Related]
38. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection.
Horsmans Y; Berg T; Desager JP; Mueller T; Schott E; Fletcher SP; Steffy KR; Bauman LA; Kerr BM; Averett DR
Hepatology; 2005 Sep; 42(3):724-31. PubMed ID: 16116638
[TBL] [Abstract][Full Text] [Related]
39. Significance of liver negative-strand HCV RNA quantitation in chronic hepatitis C.
Yuki N; Matsumoto S; Tadokoro K; Mochizuki K; Kato M; Yamaguchi T
J Hepatol; 2006 Feb; 44(2):302-9. PubMed ID: 16343680
[TBL] [Abstract][Full Text] [Related]
40. The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus.
Laskus T; Radkowski M; Wilkinson J; Vargas H; Rakela J
J Infect Dis; 2002 Feb; 185(4):417-21. PubMed ID: 11865392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
